X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8533) 8533
Publication (1085) 1085
Book Chapter (124) 124
Book Review (111) 111
Newspaper Article (101) 101
Conference Proceeding (26) 26
Book / eBook (18) 18
Dissertation (14) 14
Magazine Article (2) 2
Trade Publication Article (2) 2
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5197) 5197
index medicus (4674) 4674
male (2979) 2979
animals (2599) 2599
female (2435) 2435
oncology (2164) 2164
neuroendocrine tumors (1962) 1962
cancer (1715) 1715
middle aged (1681) 1681
tumors (1681) 1681
aged (1399) 1399
endocrinology & metabolism (1379) 1379
adult (1377) 1377
expression (1086) 1086
neuroendocrine (1075) 1075
mice (1036) 1036
neurosciences (993) 993
immunohistochemistry (984) 984
metastasis (893) 893
medicine & public health (890) 890
pathology (823) 823
cell line, tumor (804) 804
neuroendocrine tumors - pathology (798) 798
cell biology (784) 784
analysis (780) 780
rats (769) 769
surgery (761) 761
prognosis (752) 752
carcinoma (747) 747
chemotherapy (716) 716
research (674) 674
article (625) 625
diagnosis (601) 601
neuroendocrine differentiation (588) 588
aged, 80 and over (572) 572
gene expression (548) 548
care and treatment (545) 545
survival (539) 539
biochemistry & molecular biology (518) 518
prostate cancer (515) 515
pancreatic neoplasms - pathology (505) 505
pancreas (481) 481
health aspects (460) 460
retrospective studies (454) 454
treatment outcome (454) 454
neuroendocrine cells (444) 444
neuroendocrine tumor (443) 443
proteins (441) 441
mutation (439) 439
management (437) 437
neuroendocrine tumors - metabolism (429) 429
carcinoma, neuroendocrine - pathology (423) 423
patients (412) 412
medicine (406) 406
neuroendocrine tumors - drug therapy (396) 396
cells (395) 395
gene-expression (377) 377
genetic aspects (374) 374
pharmacology & pharmacy (370) 370
differentiation (369) 369
lung cancer (366) 366
physiological aspects (366) 366
gastroenterology & hepatology (364) 364
growth (361) 361
signal transduction (355) 355
adenocarcinoma (349) 349
multidisciplinary sciences (349) 349
prostatic neoplasms - pathology (349) 349
peptides (347) 347
somatostatin (345) 345
lung neoplasms - pathology (344) 344
apoptosis (343) 343
endocrine tumors (343) 343
physiology (340) 340
neuroendocrine tumors - genetics (339) 339
endocrinology (338) 338
metastases (338) 338
neuroendocrine carcinoma (334) 334
neoplasm staging (331) 331
radiology, nuclear medicine & medical imaging (330) 330
neoplasms (328) 328
young adult (328) 328
gene expression regulation, neoplastic (327) 327
therapy (324) 324
adolescent (322) 322
neuroendocrine tumors - diagnosis (318) 318
brain (315) 315
antineoplastic agents - therapeutic use (314) 314
abridged index medicus (310) 310
neurons (309) 309
endocrine system (307) 307
development and progression (306) 306
research article (299) 299
prognostic-factors (298) 298
medical prognosis (296) 296
neuroendocrine tumors - therapy (280) 280
cell differentiation (278) 278
carcinoid-tumors (277) 277
hormones (274) 274
rodents (272) 272
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8654) 8654
German (50) 50
French (29) 29
Japanese (26) 26
Spanish (11) 11
Polish (5) 5
Chinese (2) 2
Portuguese (2) 2
Turkish (2) 2
Arabic (1) 1
Czech (1) 1
Finnish (1) 1
Korean (1) 1
Norwegian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Prostate, ISSN 0270-4137, 11/2003, Volume 57, Issue 3, pp. 205 - 225
Journal Article
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 03/2018, Volume 25, Issue 3, pp. 367 - 380
Experimental models of neuroendocrine tumour disease are scarce, and no comprehensive characterisation of existing gastroenteropancreatic neuroendocrine tumour... 
Inhibitor screening | GEPNET | Neuroendocrine tumour | Vorinostat | Cell lines | Exome sequencing | Immunophenotyping | Copy number alterations | Trametinib | NUDE-MICE | neuroendocrine tumour | vorinostat | cell lines | LANDSCAPE | ILEAL CARCINOIDS | MTOR PATHWAY | VALPROIC ACID | TUMOR-CELLS | ESTABLISHMENT | CANCER | trametinib | exome sequencing | ONCOLOGY | immunophenotyping | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | SEQUENCING DATA | copy number alterations | inhibitor screening | Stomach Neoplasms - genetics | Pancreatic Neoplasms - metabolism | Neuroendocrine Tumors - metabolism | Genomics | Humans | Intestinal Neoplasms - metabolism | Stomach Neoplasms - metabolism | Pancreatic Neoplasms - genetics | Stomach Neoplasms - drug therapy | DNA Copy Number Variations | Neuroendocrine Tumors - genetics | Whole Exome Sequencing | Pancreatic Neoplasms - drug therapy | Phenotype | Biomarkers, Tumor - metabolism | Neuroendocrine Tumors - drug therapy | Histone Deacetylase Inhibitors - pharmacology | Antineoplastic Agents - pharmacology | Biomarkers, Tumor - genetics | Protein Kinase Inhibitors - pharmacology | Mutation | Tumor Cells, Cultured | Intestinal Neoplasms - drug therapy | Intestinal Neoplasms - genetics | nude-mice | gene-expression | establishment | acid | exome | Endokrinologi och diabetes | valproic | ileal carcinoids | sequencing data | tumor-cells | cancer | mtor pathway | Cancer and Oncology | landscape | Cancer och onkologi | Endocrinology and Diabetes
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e88713
Recently, a novel WHO-classification has been introduced that divided gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) according to their... 
SYSTEM | MOLECULAR-PATHOGENESIS | CISPLATIN | NEOPLASMS | VESICULAR MONOAMINE TRANSPORTER | MULTIDISCIPLINARY SCIENCES | MIDGUT | GENE-EXPRESSION | COMPARATIVE GENOMIC HYBRIDIZATION | TUMORS | ENDOCRINE-CELLS | Immunohistochemistry | Carcinoma, Large Cell - pathology | Carcinoma, Neuroendocrine - ultrastructure | Cell Count | Humans | Carcinoma, Large Cell - ultrastructure | Male | Antineoplastic Agents - therapeutic use | Carcinogenesis - drug effects | Carcinogenesis - pathology | Cell Shape - drug effects | Carcinoma, Neuroendocrine - pathology | Models, Biological | Digestive System Neoplasms - pathology | Biomarkers, Tumor - metabolism | Cell Line, Tumor | Aged | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Receptors, Somatostatin - metabolism | Cytogenetic Analysis | Cytogenetics | Chemotherapy | Metastasis | Cancer | Drugs | Cell culture | Biotechnology | Carcinoma | 5-Fluorouracil | Pathogenesis | Liver | Biology | Hybridization | Kinases | Cancer therapies | Neoplasms | Lymph nodes | Metastases | Proteins | Oxaliplatin | Surgery | Penicillin | Localization | DNA fingerprinting | Growth factors | Deoxyribonucleic acid--DNA | Sensitivity analysis | Etoposide | Tumorigenicity | Gene expression | Cisplatin | Pathology | Sensitivity | Hospitals | Large intestine | Cell lines | Genetic fingerprinting | Aberration | Chromosome aberrations | Tumors | Neuroendocrine tumors | Deoxyribonucleic acid | DNA
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0182852
Journal Article
Neuroendocrinology, ISSN 0028-3835, 11/2019, Volume 109, Issue 4, pp. 346 - 361
Metastatic neuroendocrine cancer still constitutes a palliative situation, lacking promising treatment options. Oncolytic virotherapy, a novel type of... 
Research Article | RAPAMYCIN | Talimogene laherparepvec | MANAGEMENT | EVEROLIMUS | COMBINATION | ADENOVIRUS | TUMORS | NEUROSCIENCES | VIROTHERAPY | ENVELOPMENT | Immunotherapy | ENDOCRINOLOGY & METABOLISM | Oncolytic virotherapy | SUNITINIB | EXPRESSION | Neuroendocrine cancer
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 2018, Volume 25, Issue 3, p. 367
Experimental models of neuroendocrine tumour disease are scarce, and no comprehensive characterisation of existing gastroenteropancreatic neuroendocrine tumour... 
Neuroendocrine tumour | Immunophenotyping | Immunologi inom det medicinska området | Copy number alterations | Trametinib | Cell Biology | Medicinsk genetik | Medical Genetics | Inhibitor screening | GEPNET | Vorinostat | Cell lines | Exome sequencing | Cellbiologi | Immunology in the medical area
Journal Article
Molecular Oncology, ISSN 1574-7891, 01/2017, Volume 11, Issue 8, pp. 1007 - 1022
textabstractMedullary thyroid cancer (MTC) is a tumor highly resistant to chemo- and radiotherapy. Drug resistance can be induced by epigenetic changes such as... 
NGFR | Neurotrophin pathway | Everolimus | Medullary thyroid cancer | MTOR | 5-aza-2'-deoxycytidine | medullary thyroid cancer | mTOR | neurotrophin pathway | everolimus | 5‐aza‐2′‐deoxycytidine | 5-aza-2′-deoxycytidine | 5-aza-2 '-deoxycytidine | CANCER-CELLS | NEUROTROPHIN RECEPTOR | NEUROENDOCRINE TUMORS | PANCREATIC-CANCER | MEDIATED APOPTOSIS | NERVE GROWTH-FACTOR | IN-VITRO | ONCOLOGY | SIGNALING PATHWAY | COLORECTAL-CANCER | TUMOR-SUPPRESSOR | Carcinoma, Neuroendocrine - metabolism | Genome-Wide Association Study | Everolimus - pharmacology | Neoplasm Proteins - biosynthesis | Carcinoma, Neuroendocrine - drug therapy | Humans | Azacitidine - analogs & derivatives | Azacitidine - agonists | Drug Synergism | Azacitidine - pharmacology | Thyroid Neoplasms - drug therapy | Carcinoma, Neuroendocrine - pathology | Gene Expression Regulation, Neoplastic - drug effects | Everolimus - agonists | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | TOR protein | Bax protein | p53 Protein | Cytotoxicity | AKT protein | Genomes | Radiation therapy | Tumor cell lines | Drug resistance | Western blotting | 1-Phosphatidylinositol 3-kinase | Thyroid carcinoma | Signal transduction | Cell growth | Thyroid cancer | Nerve growth factor receptors | Cell lines | DNA methylation | Extracellular matrix | Mutation | Neuroendocrine tumors | Thyroid | Apoptosis
Journal Article